138 related articles for article (PubMed ID: 30556862)
1. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.
Niccoli Asabella A; Simone M; Ballini A; Altini C; Ferrari C; Lavelli V; De Luca R; Inchingolo F; Rubini G
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8227-8236. PubMed ID: 30556862
[TBL] [Abstract][Full Text] [Related]
2. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
Altini C; Niccoli Asabella A; De Luca R; Fanelli M; Caliandro C; Quartuccio N; Rubini D; Cistaro A; Montemurro S; Rubini G
Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
[TBL] [Abstract][Full Text] [Related]
3. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery.
Niccoli-Asabella A; Altini C; De Luca R; Fanelli M; Rubini D; Caliandro C; Montemurro S; Rubini G
Biomed Res Int; 2014; 2014():952843. PubMed ID: 24877151
[TBL] [Abstract][Full Text] [Related]
5. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer.
Lovinfosse P; Polus M; Van Daele D; Martinive P; Daenen F; Hatt M; Visvikis D; Koopmansch B; Lambert F; Coimbra C; Seidel L; Albert A; Delvenne P; Hustinx R
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):365-375. PubMed ID: 29046927
[TBL] [Abstract][Full Text] [Related]
7. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
[TBL] [Abstract][Full Text] [Related]
8. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.
Leccisotti L; Gambacorta MA; de Waure C; Stefanelli A; Barbaro B; Vecchio FM; Coco C; Persiani R; Crucitti A; Tortorelli AP; Giordano A; Valentini V
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):657-66. PubMed ID: 25687534
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
11. Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?
Fagundes TC; Mafra A; Silva RG; Castro ACG; Silva LC; Aguiar PT; Silva JA; P Junior E; Machado AM; Mamede M
Rev Assoc Med Bras (1992); 2018 Feb; 64(2):119-126. PubMed ID: 29641665
[TBL] [Abstract][Full Text] [Related]
12. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy.
Capirci C; Rubello D; Chierichetti F; Crepaldi G; Fanti S; Mandoliti G; Salviato S; Boni G; Rampin L; Polico C; Mariani G
AJR Am J Roentgenol; 2006 Aug; 187(2):W202-8. PubMed ID: 16861513
[TBL] [Abstract][Full Text] [Related]
14. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
[TBL] [Abstract][Full Text] [Related]
15. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
Sun W; Xu J; Hu W; Zhang Z; Shen W
Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.
Krug B; Crott R; de Cannière L; D'Hondt L; Vander Borght T
Colorectal Dis; 2013 Nov; 15(11):e627-33. PubMed ID: 24192263
[TBL] [Abstract][Full Text] [Related]
17. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.
Capirci C; Rubello D; Chierichetti F; Crepaldi G; Carpi A; Nicolini A; Mandoliti G; Polico C
Biomed Pharmacother; 2004 Oct; 58(8):451-7. PubMed ID: 15464875
[TBL] [Abstract][Full Text] [Related]
18. Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy.
Maffione AM; Ferretti A; Grassetto G; Bellan E; Capirci C; Chondrogiannis S; Gava M; Marzola MC; Rampin L; Bondesan C; Colletti PM; Rubello D
Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):853-64. PubMed ID: 23417501
[TBL] [Abstract][Full Text] [Related]
19. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]